Preclinical experiments have confirmed that in hepatocellular carcinoma models, anti-PD-L1-loaded sonosensitized nanobubbles combined with SDT not only amplify local tumor ablation but also activate anti-tumor immunity, inhibit tumor growth, and improve survival (92). This evidence concerns the gene CD274 and hepatocellular carcinoma.